Related Experiment Video
Updated: Aug 15, 2026

Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
PERK eIF2alpha kinase regulates neonatal growth by controlling the expression of circulating insulin-like growth
Yulin Li1, Kaori Iida, Jeff O'Neil
1Department of Biology, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.
Insights
PERK deficiency causes severe growth retardation in neonatal mice by reducing liver IGF-I. This highlights PERK
Area of Science:
- Endocrinology
- Molecular Biology
- Developmental Biology
Background:
- Wolcott-Rallison syndrome and PERK deficiency lead to severe postnatal growth retardation.
- Perk-/- mice exhibit proportional dwarfism and reduced chondrocyte proliferation in growth plates.
Purpose of the Study:
- Investigate the role of PERK in neonatal growth.
- Determine the mechanism linking PERK deficiency to growth retardation.
Main Methods:
- Analysis of growth parameters in Perk-/- mice.
- Measurement of IGF-I mRNA and serum levels.
- Assessment of growth hormone (GH) and IGF-I effects on growth retardation.
- Transgenic rescue of PERK activity in beta-cells.
Main Results:
- Perk-/- mice showed a 75% reduction in neonatal liver IGF-I mRNA and serum IGF-I.
- IGF-I injections partially reversed growth retardation; GH had no effect.
- PERK activity in beta-cells rescued juvenile but not neonatal growth.
- Neonatal liver IGF-I is GH-independent.
Conclusions:
- PERK regulates hepatic IGF-I expression during the GH-independent neonatal period.
- PERK deficiency causes severe neonatal growth retardation due to impaired IGF-I regulation.
- PERK is crucial for normal neonatal growth independent of GH signaling.
Abstract:
Humans afflicted with the Wolcott-Rallison syndrome and mice deficient for PERK (pancreatic endoplasmic reticulum eIF2alpha kinase) show severe postnatal growth retardation. In mice, growth retardation in Perk-/- mutants is manifested within the first few days of neonatal development. Growth parameters of Perk-/- mice, including comparison of body weight to length and organ weights, are consistent with proportional dwarfism. Tibia growth plates exhibited a reduction in proliferative and hypertrophic chondrocytes underlying the longitudinal growth retardation. Neonatal Perk-/- deficient mice show a 75% reduction in liver IGF-I mRNA and serum IGF-I within the first week, whereas the expression of IGF-I mRNA in most other tissues is normal. Injections of IGF-I partially reversed the growth retardation of the Perk-/- mice, whereas GH had no effect. Transgenic rescue of PERK activity in the insulin- secreting beta-cells of the Perk-/- mice reversed the juvenile but not the neonatal growth retardation. We provide evidence that circulating IGF-I is derived from neonatal liver but is independent of GH at this stage. We propose that PERK is required to regulate the expression of IGF-I in the liver during the neonatal period, when IGF-I expression is GH-independent, and that the lack of this regulation results in severe neonatal growth retardation.
Related Concept Videos
Cell Specific Gene Expression
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Insulin: The Receptor and Signaling Pathways

